Q32 Bio Inc.QTTBNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank89
5Y CAGR+52.4%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

5Y CAGR
+52.4%/yr
Long-term compound
Percentile
P89
Within normal range
vs 5Y Ago
8.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$12.92M-29.8%
2024$18.39M+455.7%
2023$-5.17M-46.8%
2022$-3.52M-2003.8%
2021$185000.00-88.2%
2020$1.57M-74.0%
2019$6.03M+38.6%
2018$4.35M+1404.6%
2017$-333365.00-117.1%
2016$1.95M-